Skip to main content
Professional Technical IVT

bronchioloalveolar carcinoma

Pronunciation: bron-kee-OH-low-al-VEE-oh-lar

A former classification of lung adenocarcinoma now reclassified as adenocarcinoma in situ or minimally invasive adenocarcinoma.

Full Definition

Bronchioloalveolar carcinoma (BAC) was a historical subtype of non-small cell lung cancer characterized by growth along alveolar septa without stromal invasion. This terminology was replaced in the 2011 WHO classification with more precise categories: adenocarcinoma in situ (AIS) for purely lepidic growth patterns, and minimally invasive adenocarcinoma (MIA) for tumors with minimal invasion. The term BAC should not appear in contemporary pathology reports, though it may still be referenced in older literature and clinical discussions. Understanding this reclassification is essential for accurate editorial review of thoracic oncology manuscripts.

Usage

Usage note: Obsolete term that should be flagged for updating in contemporary medical writing.

In Context

  • "The historical diagnosis of bronchioloalveolar carcinoma has been superseded by the current WHO classification." — Review article
  • "Cases previously classified as bronchioloalveolar carcinoma would now be categorized as adenocarcinoma in situ." — Pathology guideline

Also known as

BAC

Don't confuse with

adenocarcinoma in situ minimally invasive adenocarcinoma

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON